http://www.sciencemag.org/news/2019/10/reanalyzing-drug-trials-depression-chronic-pain-aims-unearth-new-data

Two new projects reanalyzing clinical trial data aim to encourage transparency in clinical research.

Concerned that reports of clinical trials can exaggerate a treatment’s benefits and downplay its risks, two research groups will sift through data from tests of drugs involving thousands of people with chronic pain or depression. The question for those reanalyzing the data is whether dozens of papers on the trials’ outcomes painted a complete picture, and what details may have gone unmentioned about the drugs’ effects.